High-Grade Ureteroscopic Biopsy Is Associated with Advanced Pathology of Upper-Tract Urothelial Carcinoma Tumors at Definitive Surgical Resection

High-Grade Ureteroscopic Biopsy Is Associated with Advanced Pathology of Upper-Tract Urothelial Carcinoma Tumors at Definitive Surgical Resection
复制标题

DOI:
10.1089/end.2011.0426
复制
发表时间:
2012-04-01
影响因子:
2.7
通讯作者:
Raman, Jay D.
Raman, Jay D.
中科院分区:
医学3区
文献类型:
--
作者:
Clements, Thomas;Messer, Jamie C.;Raman, Jay D.

文献摘要

被引文献

相似文献

背景和目的:准确评估上尿路上皮癌(UTUC)的病理学可以指导内镜治疗与摘除治疗的使用。我们提出了一个多机构队列的患者与UTUC谁接受手术切除术的特点与输尿管镜(URS)活检功能与最终pathological results.Patients和方法的关联:URS活检数据可在238例患者接受手术切除的UTUC。使用活检刷套件、机械活检装置或篮进行活检。分期为刷拭阳性,非肌肉浸润性(= pT(2))。结果:在URS活检中,88/238(37%)例患者有阳性刷检,140(59%)例诊断为非MI,10(4%)例有MI疾病。活检结果显示140例(59%)为低度癌症,98例(41%)为高度癌症。手术切除时的病理学评价显示140例(59%)患者为非MI肿瘤,98例(41%)为MI,150例(63%)为高级别疾病。在单变量分析中,高URS活检分级与手术时高分级(阳性预测值[PPV] 92%,P < 0.0001)和MI(PPV 60%,P < 0.0001)UTUC相关。然而,URS活检分期与手术病理分级相关(P = 0.005),而与MI疾病无关(P = 0.16)。在多变量分析中,高URS分级,而非活检分期,与高最终病理分级相关(风险比[HR] 16.6,95%置信区间[CI] 7.0-39.5,P < 0.0001)和MI UTUC结论:高URS活检分级与肿瘤病理学不良反应有关,而与肿瘤分期无关。这些信息可能对UTUC的风险分层和内镜治疗与手术切除的适当选择起到有价值的作用。
Background and Purpose: Accurate assessment of upper-tract urothelial carcinoma (UTUC) pathology may guide use of endoscopic vs extirpative therapy. We present a multi-institutional cohort of patients with UTUC who underwent surgical resection to characterize the association of ureteroscopic (URS) biopsy features with final pathology results.Patients and Methods: URS biopsy data were available in 238 patients who underwent surgical resection of UTUC. Biopsies were performed using a brush biopsy kit, mechanical biopsy device, or basket. Stage was classified as a positive brush, nonmuscle-invasive (= pT(2)). Grade was classified as low or high.Results: On URS biopsy, 88/238 (37%) patients had a positive brush, 140 (59%) had a diagnosis of non-MI, and 10 (4%) had MI disease. Biopsy results showed low-grade cancer in 140 (59%) and high-grade cancer in 98 (41%). Pathologic evaluation at surgical resection demonstrated non-MI tumors in 140 (59%) patients, MI in 98 (41%), and high-grade disease in 150 (63%). On univariate analysis, high URS biopsy grade was associated with high-grade (positive predictive value [PPV] 92%, P < 0.0001) and MI (PPV 60%, P < 0.0001) UTUC at surgery. URS biopsy stage, however, was associated with surgical pathology grade (P = 0.005), but not MI (P = 0.16) disease. On multivariate analysis, high URS grade, but not biopsy stage, was associated with high final pathology grade (hazard ratio [HR] 16.6, 95% confidence interval [CI] 7.0-39.5, P < 0.0001) and MI UTUC (HR 3.6, 95% CI 2.1-6.8, P < 0.0001).Conclusion: High URS biopsy grade, but not stage, is associated with adverse tumor pathology. This information may play a valuable role for risk stratification and in the appropriate selection of endoscopic management vs surgical extirpation for UTUC.